HomeINDV • LON
add
Indivior PLC
Nakaraang pagsara
GBXÂ 851.00
Sakop ng araw
GBXÂ 854.00 - GBXÂ 898.00
Sakop ng taon
GBXÂ 548.71 - GBXÂ 1,486.00
Market cap
1.11B GBP
Average na Volume
324.62K
P/E ratio
-
Dividend yield
-
Primary exchange
LON
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 266.00M | -6.34% |
Gastos sa pagpapatakbo | 152.00M | -12.14% |
Net na kita | 47.00M | 0.00% |
Net profit margin | 17.67 | 6.77% |
Kita sa bawat share | 0.41 | 10.81% |
EBITDA | 75.00M | 4.17% |
Aktuwal na % ng binabayarang buwis | 18.97% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 373.00M | 13.03% |
Kabuuang asset | 1.38B | -5.37% |
Kabuuang sagutin | 1.66B | 15.04% |
Kabuuang equity | -285.00M | — |
Natitirang share | 125.00M | — |
Presyo para makapag-book | -3.73 | — |
Return on assets | 12.32% | — |
Return on capital | 137.80% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 47.00M | 0.00% |
Cash mula sa mga operasyon | 75.00M | 236.36% |
Cash mula sa pag-invest | -5.00M | -120.00% |
Cash mula sa financing | -17.00M | 55.26% |
Net change in cash | 53.00M | 177.94% |
Malayang cash flow | 101.25M | 1,180.00% |
Tungkol
Indivior is a specialty pharmaceuticals business. Established as a division of Reckitt Benckiser in 1994 and demerged from that company in December 2014, the company has been fined for false marketing claims about the safety of its drug, Suboxone. It is listed on the London Stock Exchange and on the NASDAQ Global Select Market. Wikipedia
Itinatag
Set 26, 2014
Website
Mga Empleyado
1,000
